| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.63 | 17418594 |
| MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.98 | 21441931 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.31 | 14601052 |
| MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.97 | 15867366 |
| MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.16 | 17150277 |
| MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.52 | 18382427 17426702 15692762 16595493 18628466 17369602 15939500 18234424 15993339 15634643 15136595 16935488 15994142 15668708 18695136 17983394 16264153 15567936 16826403 16322301 11325840 16115903 16096432 19526202 |
| MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.52 | 18323546 16115903 15136595 11325840 18234424 16273361 18223236 16244791 |
| MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.42 | 16051944 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
5.00 | 12907637 12619106 21507988 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
5.00 | 17876044 16023760 18059187 16234567 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
5.00 | 16313753 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.30 | 1485588 16201981 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.71 | 6189445 |
| MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.74 | 17924179 16952015 15792986 17007740 16731534 16242529 17382496 17928571 16109756 16455267 16269455 16612575 17974986 16278810 15505089 15811867 18627295 16364871 15476868 17131338 17519947 16651473 17308081 17329180 17351982 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.04 | 17334414 16243910 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.76 | 12371664 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.17 | 19486331 |
| MESH:D003092 |
Colitis |
|
Selenium |
4.26 | 17936198 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.88 | 18259882 18802399 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
2.88 | 18802399 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
4.38 | 17416283 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
4.38 | 15131321 |
| MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.93 | 18602426 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.67 | 17359293 |
| MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.77 | 18037988 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
2.96 | 16481741 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.23 | 19224547 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
5.13 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.62 | 12168785 12639820 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.76 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.56 | 17150277 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.75 | 15692506 |
| MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.72 | 17875725 16144979 16495754 14766674 16244372 16244371 18006777 18674790 16707910 16330681 16879835 12587719 17888722 |
| MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.92 | 17481944 |
| MESH:D006333 |
Heart Failure |
|
Selenium |
7.92 | 17162251 |
| MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.27 | 15692506 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.96 | 15720958 |
| MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.73 | 18501091 15147373 17606976 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.20 | 10903974 |
| MESH:D007251 |
Influenza, Human |
|
Selenium |
4.81 | 16624496 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.05 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.72 | 8314463 18776723 10903974 |
| MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.72 | 15369732 16775033 15699352 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
11.25 | 16707910 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
11.25 | 16518626 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.04 | 12371664 |
| MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.77 | 16085563 |
| MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
5.23 | 17353645 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.15 | 16595196 16439617 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
2.45 | 18177683 15890375 2125692 9163691 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.83 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.83 | 17085340 16842330 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.71 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.71 | 17418594 6189445 |
| MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.70 | 16098063 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
10.00 | 17654614 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
10.00 | 14749477 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
5.05 | 15621674 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.91 | 15458769 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.91 | 15318939 |
| MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.83 | 16827129 |
| MESH:D008545 |
Melanoma |
|
Paclitaxel |
3.83 | 16342250 12025231 12040289 |
| MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.67 | 17638057 |
| MESH:D008654 |
Mesothelioma |
|
Selenium |
6.67 | 15107826 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.40 | 16801185 |
| MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.87 | 15792986 |
| MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.33 | 17415656 |
| MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.93 | 14749477 |
| MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.07 | 15857846 19429709 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.52 | 18259882 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
6.52 | 15867366 |
| MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.25 | 16899518 16636307 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.05 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
10.40 | 19348381 18481113 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
10.40 | 15640375 16889571 |
| MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.42 | 15555623 |
| MESH:D010014 |
Osteolysis |
|
Paclitaxel |
5.52 | 15867366 |
| MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.40 | 15930896 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
3.07 | 11161223 |
| MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.77 | 17983394 |
| MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.50 | 15087411 |
| MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.77 | 17638057 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.55 | 12371664 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.53 | 15897917 16888761 18437689 16868541 16729912 15749863 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
3.53 | 17172428 16729912 16356831 17136230 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.32 | 16882103 |
| MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.70 | 17922066 |
| MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.34 | 18313854 16767912 15675481 17710206 17203757 15625365 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.68 | 16326096 14601052 |
| MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.33 | 17846226 |
| MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.09 | 15692506 |
| MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
5.05 | 15625365 16767912 17203757 |
| MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
2.45 | 18506536 18396642 |
| MESH:D024801 |
Tauopathies |
|
Paclitaxel |
5.35 | 16930453 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.64 | 17909728 16010429 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.87 | 17653716 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.59 | 1336536 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.70 | 17334414 17638931 17678736 16364871 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.05 | 17120751 |